OTCM
BLGO
Market cap26mUSD
Oct 08, Last price
0.08USD
1D
7.81%
1Q
-27.60%
Jan 2017
-89.98%
Name
BioLargo Inc
Chart & performance
P/E
—
P/S
3.43
EPS
—
Div yield, %
—
Shrs. gr., 5y
9.39%
Rev. gr., 5y
26.13%
Revenues
8m
-56.32%
Net income
-12m
L+390.42%
CFO
-8m
L+158.80%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
BioLargo, Inc. pioneers the invention, development, and commercialization of sophisticated platform technologies. The company is dedicated to tackling critical environmental challenges, such as per- and polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater purification, managing industrial odors and volatile organic compounds (VOCs), enhancing air quality, and controlling infections. Backed by numerous issued patents, BioLargo maintains a robust product pipeline and extends its expertise through comprehensive environmental engineering services. Among its notable innovations are the Advanced Oxidation system, a water treatment solution generating potent oxidative and energetic iodine species; the Aqueous Electrostatic Concentrator, specifically designed for eliminating PFAS from water; CupriDyne Clean industrial products, which effectively neutralize stubborn odors and VOCs across various industrial settings; and specialized advanced wound care products. Established in 1991, BioLargo, Inc. is headquartered in Westminster, California.
Key people
Dennis Calvert
Chairman of the Board, President, Chief Executive Officer · since 2008
Charles Dargan
Chief Financial Officer · since 2008
Kenneth Code
Chief Scientific Officer, Director · since 2007
Joseph Provenzano
Executive Vice President - Operations, Corporate Secretary, Director · since 2008
Christina Bray
Independent Director · since 2022
Dennis Marshall
Independent Director · since 2006
Linda Park
Independent Director · since 2022
Jack Strommen
Independent Director · since 2017
Legal address
C/O AGENTS AND CORPORATIONS, INC.
1201 ORANGE ST
STE 600
ONE COMMERCE CENTER
WILMINGTON, DE 19801
US
1201 ORANGE ST
STE 600
ONE COMMERCE CENTER
WILMINGTON, DE 19801
US
Headquarters
14921 Chestnut Street
Westminster, CA 92683
US
Westminster, CA 92683
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||